Unibest 优贝德
登录 / 注册
← 返回专利悬崖列表

CAS 1782938-16-2

(1S,2S,3S,4S)-2-(2-[[tert-Butyl(diphenyl)silyl]oxy]ethyl)-4-(methoxymethoxy)-2-methyl-3-[(4S,5S)-6,6,8-trimethyl-2,9-dioxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]cyclohexyl benzoate

登记编号:(XXIX)101438-55-b,(XXIX)101438-55-c

应用背景(按来源药适应症)

乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate

来源药(使用该中间体的合成路线)

品种梯队到期年
Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylateTier C · 观察 / 贸易-

合成路线中的位置(上下游链)

按路线登记顺序排列,左→右为合成方向;高亮为当前 CAS,其余可点击跳转对应档案。

Paclitaxel/Encequidar mesylate优化路线步数:9总收率:/
(1S)-1-[(S)-[(1R,2S,3S,6S)-3-(Benzyloxy)-2-(2-[[tert-butyl(diphenyl)silyl]oxy]ethyl)-6-(methoxymethoxy)-2-methylcyclohexyl](hydroxy)methyl]-2,2,4-trimethylcyclohex-3-en-1-ol→(2-[(1S,2R,3S,6S)-6-(Benzyloxy)-3-(methoxymethoxy)-1-methyl-2-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclohexyl]ethoxy)(tert-butyl)diphenylsilane→(1S,2S,3S,4S)-2-(2-[[tert-Butyl(diphenyl)silyl]oxy]ethyl)-4-(methoxymethoxy)-2-methyl-3-[(4S,5S)-6,6,8-trimethyl-2,9-dioxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]cyclohexyl benzoate→(1S,2S,3S,6S)-3-(Benzyloxy)-2-(2-[[tert-butyl(diphenyl)silyl]oxy]ethyl)-6-(methoxymethoxy)-2-methylcyclohexanecarbaldehyde→(4S,5S)-4-[(1S,2S,3S,6S)-3-(Benzyloxy)-2-(2-[[tert-butyl(diphenyl)silyl]oxy]ethyl)-6-(methoxymethoxy)-2-methylcyclohexyl]-6,6,8-trimethyl-1,3-dioxaspiro[4.5]dec-7-en-2-one→(S)-[(1R,2S,3S,6S)-3-(Benzyloxy)-2-(2-[[tert-butyl(diphenyl)silyl]oxy]ethyl)-6-(methoxymethoxy)-2-methylcyclohexyl](4,6,6-trimethylcyclohexa-1,4-dien-1-yl)methanol→(S)-[(1R,2S,3S,6S)-3-(Benzyloxy)-2-(2-[[tert-butyl(diphenyl)silyl]oxy]ethyl)-6-(methoxymethoxy)-2-methylcyclohexyl][(1S,6S)-2,2,4-trimethyl-7-oxabicyclo[4.1.0]hept-3-en-1-yl]methanol→[(1R,2S,3S,6S)-3-(Benzyloxy)-2-(2-[[tert-butyl(diphenyl)silyl]oxy]ethyl)-6-(methoxymethoxy)-2-methylcyclohexyl]methanol→2-[(1S,2R,3S,6S)-6-(Benzyloxy)-3-(methoxymethoxy)-1-methyl-2-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclohexyl]ethanol→2-[[(1R,2S,3S,6S)-3-(Benzyloxy)-6-(methoxymethoxy)-2-methyl-2-vinylcyclohexyl]methoxy]tetrahydro-2H-pyran→2,4,6-Triisopropyl-N'-[(1Z)-2,2,4-trimethylcyclohex-3-en-1-ylidene]benzenesulfonohydrazide→Bis(trichloromethyl) carbonate
Paclitaxel/Encequidar mesylate优化路线步数:4总收率:/
(1S,2S,3S,4S)-2-(2-[[tert-Butyl(diphenyl)silyl]oxy]ethyl)-4-(methoxymethoxy)-2-methyl-3-[(4S,5S)-6,6,8-trimethyl-2,9-dioxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]cyclohexyl benzoate→(1S,2S,3S,4S)-2-(2-[[tert-Butyl(diphenyl)silyl]oxy]ethyl)-3-[(4S,5S,9R)-9-hydroxy-6,6,8-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]-4-(methoxymethoxy)-2-methylcyclohexyl benzoate→(4S,5S,7R)-4-[(1S,2S,3S,6S)-3-(Benzoyloxy)-2-(2-[[tert-butyl(diphenyl)silyl]oxy]ethyl)-6-(methoxymethoxy)-2-methylcyclohexyl]-8,10,10-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-8-en-7-yl benzoate→(4S,5S,7R)-4-[(1S,2S,3S,6S)-3-(Benzoyloxy)-2-(2-hydroxyethyl)-6-(methoxymethoxy)-2-methylcyclohexyl]-8,10,10-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-8-en-7-yl benzoate→(4S,5S)-4-[(1S,2S,3S,6S)-3-(Benzoyloxy)-6-(methoxymethoxy)-2-methyl-2-(2-oxoethyl)cyclohexyl]-8,10,10-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-8-en-7-yl benzoate→(3aS,7S,8R,9aS,10S,13S,13aS,13bS)-8-Hydroxy-13-(methoxymethoxy)-6,9a,14,14-tetramethyl-2-oxo-7,8,9,9a,10,11,12,13,13a,13b-decahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-10-yl benzoate

本站可供应的对应中间体

目录暂未收录该靶点的在售中间体 —— 可直接发起询价,需求会进入撮合池。

本页为中间体 CAS 注册档案:同 CAS 的多条路线登记已合并;后续供应商报价与买方需求以该 CAS 为主键撮合。